Venprix Pharmaceuticals Private Limited
About Venprix Pharmaceuticals Private Limited
Data last updated:
Venprix Pharmaceuticals Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 17 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24100KA2018PTC110228. Its GSTIN is 33AAGCV2886A1ZG (Tamil Nadu).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Natarajan Umarani and Natarajan Jayaraman.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D.No 17 18th Cross Puttenahallipalya Jp Nagar 7th Phase, Bengaluru, Karnataka, India – 560078.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.6 Lakh, a decline of 34% compared to the previous year. For the same year it recorded a net profit of ₹30,767 (net margin 2.9%) and EBITDA of ₹1.27 Lakh (EBITDA margin 12%).
As per MCA filings, the company has open charges of ₹8 Lakh on record.
Company details
Contact details
Venprix Pharmaceuticals Private Limited's registered office is in Bengaluru, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD.No 17 18th Cross Puttenahallipalya Jp Nagar 7th Phase, Bengaluru, Karnataka, India – 560078
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Venprix Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Venprix Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Venprix Pharmaceuticals Private Limited, buy the company report.
Financials of Venprix Pharmaceuticals Private Limited
FY 2025 filings availableVenprix Pharmaceuticals Private Limited reported revenue of ₹10.6 Lakh (down 34% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 34% in the latest year. EBITDA rose 76% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹30,767 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Venprix Pharmaceuticals Private Limited, buy the company report.
Board of directors of Venprix Pharmaceuticals Private Limited
Venprix Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Natarajan Umarani | Director | 17 Feb 2018 | 8 Years 8 Months | Current |
| Natarajan Jayaraman | Additional Director | 02 Sep 2025 | 1 Years 1 Months | Current |
Auditor
Venprix Pharmaceuticals Private Limited is audited by CHARLES & CHANDRASEKAR for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHARLES & CHANDRASEKAR | FY 2019 | 005759S |
Shareholding
The shareholding of Venprix Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Venprix Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Nov 2022 | 100643514 | Others | ₹8 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Venprix Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Venprix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Venprix Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAGCV2886A1ZG | Tamil Nadu | Active | 13 Apr 2022 |
To see the full GST registrations and return filing status of Venprix Pharmaceuticals Private Limited, buy the company report.
Recent activity
Venprix Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Natarajan Jayaraman was appointed as Additional Director on 02 Sep 2025.
Frequently asked questions
Venprix Pharmaceuticals is an active private limited company based in Bengaluru, Karnataka, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 17 February 2018 (8+ years old) and is registered under CIN U24100KA2018PTC110228.
Venprix Pharmaceuticals has 2 current directors:
- Natarajan Umarani - Director
- Natarajan Jayaraman - Additional Director
The latest financial statements of Venprix Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Venprix Pharmaceuticals is 33AAGCV2886A1ZG, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Venprix Pharmaceuticals is U24100KA2018PTC110228. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Venprix Pharmaceuticals was incorporated on 17 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
Natarajan Jayaraman was appointed as Additional Director on 02 Sep 2025. Natarajan Umarani was appointed as Director on 17 Feb 2018. Selvaraj Nathiya was appointed as Director on 17 Feb 2018.
The registered office of Venprix Pharmaceuticals is at D.No 17 18th Cross Puttenahallipalya Jp Nagar 7th Phase, Bengaluru, Karnataka, India – 560078.
Venprix Pharmaceuticals operates in the chemicals and materials industry, in the industrial chemicals segment.
Venprix Pharmaceuticals has open charges of ₹8 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
